9QRM | pdb_00009qrm

X-ray structure of Kp32gp38 in complex with K21 pyr5


Experimental Data Snapshot

  • Method: X-RAY DIFFRACTION
  • Resolution: 1.80 Å
  • R-Value Free: 
    0.235 (Depositor), 0.237 (DCC) 
  • R-Value Work: 
    0.188 (Depositor), 0.188 (DCC) 
  • R-Value Observed: 
    0.191 (Depositor) 

Starting Model: experimental
View more details

wwPDB Validation   3D Report Full Report


This is version 1.1 of the entry. See complete history


Literature

Structural and functional features of Klebsiella pneumoniae capsular degradation by the phage depolymerase KP32gp38: Implications for vaccination against K. pneumoniae.

Napolitano, V.Privitera, M.Drulis-Kawa, Z.Marasco, D.Fallarini, S.Berisio, R.Squeglia, F.

(2025) Int J Antimicrob Agents 66: 107596-107596

  • DOI: https://doi.org/10.1016/j.ijantimicag.2025.107596
  • Primary Citation of Related Structures:  
    9QRM

  • PubMed Abstract: 

    The Klebsiellapneumoniae Przondovirus KP32 presents a complex capsular degradation machinery, composed of the two serotype-specific depolymerases KP32gp38 and KP32gp37. In this work, we performed CPS degradation assays combined with mass spectrometry approaches to identify the reaction product of the K21 serotype CPS degradation by KP32gp38. We determined the crystal structure of the KP32gp38 depolymerase in complex with the identified degradation product, a pyruvated pentasaccharide, named K21-pyr5. The structure shows that K21-pyr5 binds to the inter-chain catalytic site, allowing the identification of important residues for CPS recognition. Importantly, we observed that the production of K21-pyr5 through CPS degradation by KP32gp38 can induce the maturation and differentiation of Monocyte-Derived Dendritic Cells which, in turn, induce lymphocyte proliferation and Th polarisation. On analogy with the T7 phage of Escherichia coli, we provide insights into the portal assembly of the Przondovirus K32. Our modelling studies suggest that the KP32 portal, attached to its icosahedral capsid shell, carries twelve depolymerase molecules on a single virion, arranged in six branches; in each branch, KP32gp38 depolymerase is grabbed on KP32gp37, which directly connected to the phage portal. Overall, our results suggest that depolymerases act as anti-virulent agents not only by depleting bacteria of their CPS but also by producing immunostimulatory CPS degradation products. This points to the use of CPS degradation products by depolymerases as potential antigens in vaccination strategies against K. pneumoniae.


  • Organizational Affiliation
    • Institute of Biostructures and Bioimaging, CNR, Napoli, Italy.

Macromolecules
Find similar proteins by:  (by identity cutoff)  |  3D Structure
Entity ID: 1
MoleculeChains Sequence LengthOrganismDetailsImage
Depolymerase 2, capsule K21-specificA [auth B]584Klebsiella pneumoniaeMutation(s): 0 
Gene Names: 38
UniProt
Find proteins for D1L2X1 (Klebsiella phage KP32)
Explore D1L2X1 
Go to UniProtKB:  D1L2X1
Entity Groups  
Sequence Clusters30% Identity50% Identity70% Identity90% Identity95% Identity100% Identity
UniProt GroupD1L2X1
Sequence Annotations
Expand
  • Reference Sequence
Oligosaccharides

Help

Entity ID: 2
MoleculeChains Length2D Diagram Glycosylation3D Interactions
(2~{S},4~{a}~{S},6~{R},7~{S},8~{R},8~{a}~{R})-2-methyl-6,7,8-tris(oxidanyl)-4,4~{a},6,7,8,8~{a}-hexahydropyrano[3,2-d][1,3]dioxine-2-carboxylic acid-(4-4)-beta-D-glucopyranose-(1-3)-alpha-D-mannopyranose-(1-2)-alpha-D-mannopyranose-(1-3)-beta-D-galactopyranoseB [auth A]5N/AN/A
Experimental Data & Validation

Experimental Data

  • Method: X-RAY DIFFRACTION
  • Resolution: 1.80 Å
  • R-Value Free:  0.235 (Depositor), 0.237 (DCC) 
  • R-Value Work:  0.188 (Depositor), 0.188 (DCC) 
  • R-Value Observed: 0.191 (Depositor) 
Space Group: P 3 2 1
Unit Cell:
Length ( Å )Angle ( ˚ )
a = 70.492α = 90
b = 70.492β = 90
c = 205.594γ = 120
Software Package:
Software NamePurpose
REFMACrefinement
HKL-3000data reduction
HKL-3000data scaling
PHASERphasing

Structure Validation

View Full Validation Report



Entry History & Funding Information

Deposition Data


Funding OrganizationLocationGrant Number
NextGenerationEU-MUR PNRR Extended Partnership initiative on Emerging Infectious Diseases (INF-ACT)Italy0001554

Revision History  (Full details and data files)

  • Version 1.0: 2025-09-03
    Type: Initial release
  • Version 1.1: 2025-10-01
    Changes: Database references